Yahoo
    HKSE - Delayed Quote HKD

    TransThera Sciences (Nanjing), Inc. (2617.HK)

    8.235 +0.305 (+3.85%)
    As of 2:00:59 PM GMT+8. Market Open.
    Loading Chart for 2617.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China

    Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China
    PR Newswire 2mo ago
    NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

    NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
    PR Newswire 10mo ago
    TransThera Sciences (Nanjing) (SEHK:2617): Taking Stock of Valuation After a Sharp Multi‑Month Rally

    TransThera Sciences (Nanjing) (SEHK:2617): Taking Stock of Valuation After a Sharp Multi‑Month Rally
    Simply Wall St. 10mo ago
    TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

    TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet
    PR Newswire 10mo ago
    INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

    INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
    PR Newswire 10mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: